From Coffee to Collaboration: Bringing ASCEND to Life with AMGEN
How ASCEND came to be and the instrumental role Amgen played to help shape this revolutionary platform for preclinical pharmaceutical research
How ASCEND came to be and the instrumental role Amgen played to help shape this revolutionary platform for preclinical pharmaceutical research
In partnering with industry-leading biotech research publisher Mary Ann Liebert, Inc., BenchSci continues to empower scientists in making discoveries with clinical benefits.
New BenchSci feature includes on- and off-target scores and off-target site sequences with highlighted mismatches for RNA-based reagents
We’ve added data from 20 million new protein experiments to our database, along with amino acid coordinates and protein structural data.
We’re leveraging three gene expression databases to empower scientists with even more unique insights into cell product gene expression profiles.
Preprint data is now discoverable via BenchSci, empowering scientists with unique insights from the most cutting-edge biomedical research.
It’s helping scientists make unprecedented advancements in the study of biology, but working with CRISPR has its challenges. Here’s how BenchSci can help.
Scientists can now find appropriate PCR primers and probes for their specific experimental context quickly and efficiently on BenchSci.
Read about some of the impactful BenchSci features that were inspired by feedback from scientists who use our platform.